{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:16:36Z","timestamp":1793380596717,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.spinee.2013.08.060","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T08:00:38Z","timestamp":1389168038000},"page":"552-559","source":"Crossref","is-referenced-by-count":386,"title":["Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery"],"prefix":"10.1016","volume":"14","author":[{"given":"Chadi A.","family":"Tannoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard S.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2013.08.060_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00003086-200202000-00002","article-title":"Bone: formation by autoinduction. 1965","author":"Urist","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.spinee.2013.08.060_bib2","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1073\/pnas.85.24.9484","article-title":"Purification and characterization of other distinct bone-inducing factors","volume":"85","author":"Wang","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spinee.2013.08.060_bib3","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","article-title":"Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)","volume":"85-A","author":"Cheng","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2013.08.060_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","article-title":"Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages","volume":"15","author":"Burkus","year":"2002","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2013.08.060_bib5","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1097\/00007632-200211010-00015","article-title":"Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2","volume":"27","author":"Burkus","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.brs.0000206357.88287.5a","article-title":"Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft","volume":"31","author":"Burkus","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3171\/spi.2004.1.1.0019","volume":"1","author":"Mummaneni","year":"2004","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3171\/spi.2005.3.6.0436","article-title":"Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2","volume":"3","author":"Villavicencio","year":"2005","journal-title":"J Neurosurg Spine"},{"issue":"Suppl","key":"10.1016\/j.spinee.2013.08.060_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.bsd.0000132291.50455.d0","article-title":"Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results","volume":"18","author":"Schwender","year":"2005","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2013.08.060_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.spinee.2006.06.381","article-title":"Posterolateral lumbar spine fusion with INFUSE bone graft","volume":"7","author":"Glassman","year":"2007","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib11","doi-asserted-by":"crossref","first-page":"E680","DOI":"10.1097\/BRS.0b013e3181844eca","article-title":"Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results","volume":"33","author":"Papakostidis","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/BRS.0b013e318074c366","article-title":"The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers","volume":"32","author":"Glassman","year":"2007","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00586-008-0799-2","article-title":"Posterior lumbar interbody fusion using rhBMP-2","volume":"17","author":"Meisel","year":"2008","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib14","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1097\/BRS.0b013e31817bd91e","article-title":"Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion","volume":"33","author":"Mulconrey","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.7326\/0003-4819-158-12-201306180-00006","article-title":"Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis","volume":"158","author":"Fu","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.spinee.2013.08.060_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-158-12-201306180-00005","article-title":"Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data","volume":"158","author":"Simmonds","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.spinee.2013.08.060_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.2009.956","article-title":"Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures","volume":"302","author":"Cahill","year":"2009","journal-title":"JAMA"},{"issue":"16 Suppl 1","key":"10.1016\/j.spinee.2013.08.060_bib18","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/00007632-200208151-00017","article-title":"Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: an evidence-based modeling approach","volume":"27","author":"Ackerman","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.spinee.2007.03.004","article-title":"The perioperative cost of infuse bone graft in posterolateral lumbar spine fusion","volume":"8","author":"Glassman","year":"2008","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib20","unstructured":"United States Food and Drug Administration, Department of Health and human services, Center for devices and Radiological Health. INFUSE bone graft\/LT-cage? Lumbar tapered fusion devices\u2014P000058. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cftopic\/pma\/pma.cfm?num5P000058.\u00a02002."},{"key":"10.1016\/j.spinee.2013.08.060_bib21","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1097\/00007632-200212010-00005","article-title":"Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies","volume":"27","author":"Boden","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib22","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1097\/BRS.0b013e31818a314d","article-title":"The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study","volume":"33","author":"Vaccaro","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib23","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/BRS.0b013e3181a396a1","article-title":"Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review","volume":"34","author":"Mindea","year":"2009","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.spinee.2009.04.004","article-title":"Complications associated with single-level transforaminal lumbar interbody fusion","volume":"9","author":"Rihn","year":"2009","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.spinee.2010.06.020","article-title":"Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion","volume":"10","author":"Muchow","year":"2010","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00586-010-1494-7","article-title":"Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion","volume":"20","author":"Owens","year":"2011","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib27","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1097\/BRS.0b013e31815b7596","article-title":"Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis","volume":"32","author":"Joseph","year":"2007","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.spinee.2010.07.005","article-title":"Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2\u2014but what is the cost?","volume":"11","author":"Mannion","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.spinee.2007.06.014","article-title":"Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF\/TLIF use of bone morphogenetic protein-2 (BMP-2)","volume":"8","author":"Wong","year":"2008","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.bsd.0000211231.83716.4b","article-title":"Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2)","volume":"19","author":"McClellan","year":"2006","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2013.08.060_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.spinee.2007.01.011","article-title":"Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases","volume":"7","author":"Lewandrowski","year":"2007","journal-title":"Spine J"},{"issue":"9 Suppl","key":"10.1016\/j.spinee.2013.08.060_bib32","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/BRS.0b013e3181d81ef2","article-title":"Complications related to osteobiologics use in spine surgery: a systematic review","volume":"35","author":"Mroz","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.spinee.2011.02.013","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.spinee.2012.09.040","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study","volume":"12","author":"Comer","year":"2012","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/BRS.0b013e31825752bc","article-title":"Retrograde ejaculation following anterior lumbar spine surgery","author":"Lindley","year":"2012","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/BRS.0b013e31828bf36a","article-title":"Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2","volume":"38","author":"Tepper","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib37","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/01.brs.0000245863.52371.c2","article-title":"Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine","volume":"31","author":"Smucker","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib38","unstructured":"FDA Public Health Notification. Life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion. July 1, 2008. FDA."},{"key":"10.1016\/j.spinee.2013.08.060_bib39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.spinee.2006.12.006","article-title":"Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion","volume":"8","author":"Buttermann","year":"2008","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3171\/SPI\/2008\/8\/6\/529","article-title":"The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients","volume":"8","author":"Tumialan","year":"2008","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.brs.0000201424.27509.72","article-title":"Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion","volume":"31","author":"Shields","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1302\/0301-620X.89B3.18270","article-title":"Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence","volume":"89","author":"Vaidya","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.spinee.2013.08.060_bib43","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00586-007-0351-9","article-title":"Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2","volume":"16","author":"Vaidya","year":"2007","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/BSD.0b013e31815ea897","article-title":"Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions","volume":"21","author":"Vaidya","year":"2008","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2013.08.060_bib45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/BRS.0b013e3181a2da08","article-title":"Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis","volume":"34","author":"Crawford","year":"2009","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3171\/SPI-07\/09\/486","volume":"7","author":"Furlan","year":"2007","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib47","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1097\/BRS.0b013e3181f8f4d3","article-title":"Postoperative cervical myelopathy and cord compression associated with the use of recombinant bone morphogenetic protein-2 in posterior cervical decompression, instrumentation, and arthrodesis: a report of two cases","volume":"36","author":"Anderson","year":"2011","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib48","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/ten.tea.2010.0555","article-title":"High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in\u00a0vivo","volume":"17","author":"Zara","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.spinee.2013.08.060_bib49","unstructured":"FDA Advisory committee panel meeting. AMPLIFYTM rhBMP-2 matrix: Orthopaedic and Rehabilitation Devices Advisory Panel Presentation. July 27, 2010. FDA."},{"key":"10.1016\/j.spinee.2013.08.060_bib50","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/01.brs.0000172157.39513.80","article-title":"Initial fusion rates with recombinant human bone morphogenetic protein-2\/compression resistant matrix and a hydroxyapatite and tricalcium phosphate\/collagen carrier in posterolateral spinal fusion","volume":"30","author":"Glassman","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib51","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(99)70024-7","article-title":"Bone morphogenetic protein 2 exerts diverse effects on cell growth in\u00a0vitro and is expressed in human pancreatic cancer in\u00a0vivo","volume":"116","author":"Kleeff","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.spinee.2013.08.060_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s002640050148","article-title":"Measurement of total and local bone morphogenetic protein concentration in bone tumours","volume":"21","author":"Laitinen","year":"1997","journal-title":"Int Orthop"},{"key":"10.1016\/j.spinee.2013.08.060_bib53","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(19940801)74:3<842::AID-CNCR2820740309>3.0.CO;2-B","article-title":"Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas","volume":"74","author":"Yoshikawa","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.spinee.2013.08.060_bib54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00001813-199804000-00006","article-title":"Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units","volume":"9","author":"Soda","year":"1998","journal-title":"Anticancer Drugs"},{"issue":"16 Suppl 1","key":"10.1016\/j.spinee.2013.08.060_bib55","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00007632-200208151-00010","article-title":"Safety profile for the clinical use of bone morphogenetic proteins in the spine","volume":"27","author":"Poynton","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pds.2057","article-title":"Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study","volume":"20","author":"Mines","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.spinee.2013.08.060_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7150\/ijms.3859","article-title":"Effect of bone morphogenetic protein-2 on proliferation and apoptosis of gastric cancer cells","volume":"9","author":"Zhang","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.spinee.2013.08.060_bib58","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00253-011-3865-3","article-title":"BMP2 promotes migration and invasion of breast cancer cells via cytoskeletal reorganization and adhesion decrease: an AFM investigation","volume":"93","author":"Jin","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.spinee.2013.08.060_bib59","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3892\/mmr.2012.945","article-title":"Induction of estrogen receptor alpha-36 expression by bone morphogenetic protein 2 in breast cancer cell lines","volume":"6","author":"Wang","year":"2012","journal-title":"Mol Med Report"},{"key":"10.1016\/j.spinee.2013.08.060_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/lary.22345","article-title":"rhBMP-2 has adverse effects on human oral carcinoma cell lines in\u00a0vivo","volume":"122","author":"Kokorina","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.spinee.2013.08.060_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1227\/01.NEU.0000363722.42097.C2","article-title":"Bone morphogenetic proteins and cancer: review of the literature","volume":"66","author":"Thawani","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.spinee.2013.08.060_bib62","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.spinee.2012.08.375","article-title":"Does BMP-2 really cause cancer? A systematic review of the literature\u2014NASS meeting 2012","volume":"12","author":"Koehler","year":"2012","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2013.08.060_bib63","unstructured":"Pivotal study of rhBMP-2\/ACS\/LT-CAGE\u00ae for anterior lumbar interbody fusion in patients with degenerative disc disease [Clinical Trial]. Available at: http:\/\/clinicaltrials.gov\/ct2\/results?term=NCT01491386&Search=Search. Accessed April 29,\u00a02013."},{"key":"10.1016\/j.spinee.2013.08.060_bib64","doi-asserted-by":"crossref","first-page":"E1600","DOI":"10.1097\/BRS.0b013e318217668f","article-title":"Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial","volume":"36","author":"Gornet","year":"2011","journal-title":"Spine"},{"issue":"15 Suppl","key":"10.1016\/j.spinee.2013.08.060_bib65","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/01.BRS.0000076901.49567.25","article-title":"Bone morphogenetic proteins and spinal surgery","volume":"28","author":"Sandhu","year":"2003","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib66","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00007632-199902150-00003","article-title":"The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion","volume":"24","author":"Boden","year":"1999","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5435\/00124635-200503000-00006","article-title":"Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion","volume":"13","author":"Khan","year":"2005","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.spinee.2013.08.060_bib68","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00007632-200104150-00017","article-title":"Evaluation of carriers of bone morphogenetic protein for spinal fusion","volume":"26","author":"Minamide","year":"2001","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007632-200202150-00006","article-title":"Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate","volume":"27","author":"Suh","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2013.08.060_bib70","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/01.brs.0000160997.91502.3b","article-title":"Comparison of Healos\/bone marrow to INFUSE (rhBMP-2\/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion","volume":"30","author":"Kraiwattanapong","year":"2005","journal-title":"Spine"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943013019840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943013019840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T23:53:37Z","timestamp":1565049217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943013019840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1529943013019840"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2013.08.060","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}